Pl. Triozzi et al., HIV TYPE 1-REACTIVE CHEMOKINE-PRODUCING CD8(-NODES() AND CD4(+) CELLSEXPANDED FROM INFECTED LYMPH), AIDS research and human retroviruses, 14(8), 1998, pp. 643-649
The chemokines RANTES, MIP-1 alpha, and MIP-1 beta have been identifie
d as HIV-1-suppressive factors produced by CD8(+) T cells, We examined
the possibility that HIV-1-specific, chemokine-releasing T cells coul
d be expanded from the lymph nodes of patients with advanced infection
. Lymphocytes, separated from lymph nodes of patients with peripheral
blood CD4 counts less than 500/mu l obtained at diagnostic biopsies, w
ere activated with anti-CD3 monoclonal antibody, and cultured in vitro
for up to 12 days with IL-2, The phenotype, proliferative response, c
hemokine production, and anti-HIV-1 activity of the expanded cells was
examined. Cells expanded 2,4- to 49-fold from patients with as few as
15 CD4(+) cells/mu l in their peripheral blood, Expanded cells were a
mixture of CD8(+)CD45RO(+) acid CD4(+)CD45RO(+) T cells, The CD8(+) c
ells were also CD30(+)CDw60(+)CD11b(-). When challenged with autologou
s B cell targets expressing HIV-1 Env protein, unseparated expanded ce
lls, and purified CD8(+) and CD4(+) T cell subsets, proliferated and s
ecreted MIP-1 alpha and RANTES, Expanded cells were negative for HIV-1
by PCR and by culture, Culture supernatants inhibited the replication
of HIV-1 in CD4(+) cells in vitro, These studies indicate that HIV-1
can stimulate chemokine release by CD8(+) and CD4(+) cells expanded fr
om infected lymph nodes, even from individuals with advanced infection
. The numbers of chemokine-releasing T cells produced in these short-t
erm cultures may be sufficient to be applied therapeutically as an aut
ologous cellular therapy for HIV-1.